In 1,251 adults with relapsed/refractory large B-cell lymphoma given axi-cel (CIBMTR registry), 60% achieved complete response; CR at day 100 (HR 0.33) or month 6 (HR 0.24) was associated with better survival. A review of 82 articles found CR predicted 1- and 2-year OS.
Meta-analysisn = 1,251
Ghobadi et al. Impact of Complete Response on Long-Term Survival in Patients with Relapsed or Refractory Large B-cell Lymphoma: A Center for International Blood and Marrow Transplant Research Prospective Study and Systematic Literature Review/Meta-Analysis